Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert F Storey

Showing results (381-390 of 401) with videos related to

Pageof 41
Sort By:
The American Journal of Cardiology|March 6, 2024
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 RegistrySanjit S Jolly, Shun Fu Lee, Rajibul Mian, et al.
The New England Journal of Medicine|November 18, 2024
Colchicine in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Shun Fu Lee, et al.
Journal of the American College of Cardiology|September 11, 2020
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary DiseaseTej Sheth, Natalia Pinilla-Echeverri, Raul Moreno, et al.
Heart (British Cardiac Society)|September 4, 2025
Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trialMarc-André d'Entremont, Sanjit S Jolly, Faisal Alharthi, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
Thrombosis and Haemostasis|November 22, 2019
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC TrialAnne H Tavenier, Renicus S Hermanides, Enrico Fabris, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
The New England Journal of Medicine|September 2, 2014
Prehospital ticagrelor in ST-segment elevation myocardial infarctionGilles Montalescot, Arnoud W van 't Hof, Frédéric Lapostolle, et al.
Cardiovascular Research|February 16, 2019
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary interventionThorsten Kessler, Bernhard Wolf, Niclas Eriksson, et al.
Heart (British Cardiac Society)|May 16, 2024
Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4)Mina Ghobrial, Hazel Haley, Rebecca Gosling, et al.
Pageof 41

Showing results (381-390 of 401) with videos related to

Sort By:
Pageof 41
The American Journal of Cardiology|March 6, 2024
SYNERGY-Everolimus-Eluting Stent With a Bioabsorbable Polymer in ST-Elevation Myocardial Infarction: CLEAR SYNERGY OASIS-9 RegistrySanjit S Jolly, Shun Fu Lee, Rajibul Mian, et al.
The New England Journal of Medicine|November 18, 2024
Colchicine in Acute Myocardial InfarctionSanjit S Jolly, Marc-André d'Entremont, Shun Fu Lee, et al.
Journal of the American College of Cardiology|September 11, 2020
Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary DiseaseTej Sheth, Natalia Pinilla-Echeverri, Raul Moreno, et al.
Heart (British Cardiac Society)|September 4, 2025
Benefit-risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trialMarc-André d'Entremont, Sanjit S Jolly, Faisal Alharthi, et al.
JAMA Cardiology|September 21, 2022
Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical TrialShamir R Mehta, Jia Wang, David A Wood, et al.
Thrombosis and Haemostasis|November 22, 2019
Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors on Top of Ticagrelor in STEMI: A Subanalysis of the ATLANTIC TrialAnne H Tavenier, Renicus S Hermanides, Enrico Fabris, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
The New England Journal of Medicine|September 2, 2014
Prehospital ticagrelor in ST-segment elevation myocardial infarctionGilles Montalescot, Arnoud W van 't Hof, Frédéric Lapostolle, et al.
Cardiovascular Research|February 16, 2019
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary interventionThorsten Kessler, Bernhard Wolf, Niclas Eriksson, et al.
Heart (British Cardiac Society)|May 16, 2024
Modelled impact of virtual fractional flow reserve in patients undergoing coronary angiography (VIRTU-4)Mina Ghobrial, Hazel Haley, Rebecca Gosling, et al.
Pageof 41